The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood ...

Device offers alternative to blood thinners for patients with atrial fibrillation ...

Boston Scientific Corporation (NYSE: BSX) today announced positive six-month primary endpoint results from the SIMPLAAFY randomized controlled trial of the WATCHMAN FLX™ Pro Left Atrial Appendage ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro ...

TidalHealth Peninsula Regional recently performed its 700th WATCHMAN procedure, marking a significant milestone for the medical center, according to a community announcement. The WATCHMAN procedure is ...

Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage ...

North Alabama Medical Center has reached a new milestone in its cardiac care program, completing its 200th WATCHMAN procedure for patients with atrial fibrillation. Dr. Oluwole Adegbala, MD, MPH, ...

Physicians with limited experience closing the left atrial appendage (LAA) with the Watchman device (Boston Scientific) in patients with atrial fibrillation do not appear to have worse clinical ...

JACKSONVILLE, Fla. -- Nearly six million Americans suffer from Atrial fibrillation. It's the most common type of irregular heartbeat. A common treatment is blood thinners but those don't work for ...

Caution: Aspirin alone or reduced dose NOAC alone following LAAC with the WATCHMAN FLX Pro LAAC Device is an investigational post-implant drug regimen.